Fred Telling - 30 Mar 2022 Form 4 Insider Report for ORAGENICS INC (OGEN)

Role: Director
Signature: /s/ Mark A. Catchur, as Attorney-in-Fact for Frederick W. Telling
Issuer symbol: OGEN
Transactions as of: 30 Mar 2022
Net transactions value: +$66,053
Form type: 4
Filing time: 01 Apr 2022, 16:05:34 UTC
Previous filing: 17 Dec 2021
Next filing: 20 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	OGEN	Common Stock	Purchase	$45,284	+124,785	+21%	$0.3629	720,863	30 Mar 2022	Direct	F1
transaction	OGEN	Common Stock	Purchase	$20,769	+59,053	+8.2%	$0.3517	779,916	31 Mar 2022	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Content

The prices reported in Column 4 are a weighted average prices. These shares were purchased in multiple transactions ranging from $0.3510 to $0.3773 on March 30, 2022 and from $0.3407 to $0.3772 on March 31, 2022. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.